Global Blood Therapeutics - CA San Mateo, South San Francisco 94080

Global Blood Therapeutics entered the industry of Biotherapeutics in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 424210, which describes it as a Biotherapeutics. For further clarification, the SIC classifies this business under the code 5122 and described it as a Biotherapeutics. The business provides service to the BOTH market.

To acquire more information, please contact Mark Goldsmith by calling (650) 741-7700 during business hours. You can also write to the business’ Single Location at 400 East Jamie Court # 101, South San Francisco, California CA 94080. You can also visit the company’s website at globalbloodtx.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Global Blood Therapeutics
Representative: Mark Goldsmith
Place of Business: 400 East Jamie Court # 101, South San Francisco, CA 94080
Contact Number: (650) 741-7700
Website: globalbloodtx.com
Type of Service: Biotherapeutics
SIC Number: 5122
NAICS Number: 424210
Locality: Single Location
Market Type: B2B & B2C
Began: 2011
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Global Blood Therapeutics is a company operating from San Mateo, California providing professional Biotherapeutics and relevant BOTH variables. It was founded in 2011 and registered with the SIC code 5122 as Biotherapeutics, and with the NAICS code 424210 as Biotherapeutics.

With a current employee count of 1 to 4, Global Blood Therapeutics has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Mark Goldsmith at (650) 741-7700 for related queries, or to locate its Single Location using the coordinates 37.649025,-122.387108.

The Single Location can also be found at the street address 400 East Jamie Court # 101 in South San Francisco, California 94080 and can be engaged online through the company website at globalbloodtx.com, the company Twitter , and Facebook page .